Amgen AIMOVIG Social Media Feed
Amgen’s AIMOVIG is a CGRP pathway treatment for the prevention of migraines in adults. Until recently, it has a robust DTC social media presence, primarily focused on Instagram. From 2021-2022, I helped establish and maintain that presence by creating:
• Social media posts that were based on the AIMOVIG campaign
• Product information posts
• Hundreds of MLR-approved responses to common questions and comments left by follower and the general public
• Long-form influencer videos that were then used for a variety of cut-downs
